By Yossi Bar, CEO and Founder of LEM Surgical. November 1^st, 2026.

 1. Preview

The global surgical landscape is approaching an operational breaking point. We are rapidly transitioning from an era defined by human manual labor into Surgery 3.0, an era defined by Physical AI and autonomous robotics. However, the adoption of autonomous surgical humanoids is not simply a clinical upgrade. It is a macroeconomic necessity driven by shifting demographics, tightening hospital margins, and a looming deficit of experienced surgeons.

2. The True Scarcity: The 20-Year Experience Gap

Healthcare professionals often mistake the current workforce crisis as a simple numbers game, but the true bottleneck is the catastrophic loss of the experienced primary attending surgeon. The most scarce and valuable resource in the hospital is the 50 to 60-year-old master surgeon. According to recent demographic analyses, nearly a third of surgeons currently in practice are over 55 years old [1]. When this master class of surgeons retires, the resulting void cannot be filled by simply recruiting more medical students.

Even if aggressive government and hospital initiatives successfully incentivize a massive influx of young doctors into surgical residencies today, the healthcare system still faces an unavoidable 20-year experience deficit. It takes roughly two decades of rigorous residencies, specialized fellowships, and thousands of independent clinical repetitions for a newly minted surgeon to achieve the cognitive mastery, procedural speed, and tactile intuition of a retiring attending. You cannot replace 30 years of operating room experience with a new graduate.

Consequently, the supply of surgeons is projected to continuously decrease into the late 2030s. A study commissioned by the Association of American Medical Colleges projects a shortfall of between 40,800 and 104,900 physicians by 2030 [2]. For all specialties, retirement decisions of practicing doctors will have the greatest effect on future physician supply, as more than one-third of all active physicians will be 65 or older in the next 10 years [2]. In orthopedic surgery specifically, this demographic cliff is even more acute: workforce data published by the American Academy of Orthopedic Surgeons (AAOS) and the AAMC indicates that 11,191 orthopedic surgeons, representing 60 percent of the active US orthopedic workforce, will be over the age of 65 by 2031, with an estimated 40.1 percent already aged 60 or older [3, 4]. As a result, peer-reviewed analyses of United States federal government projections from the Health Resources and Services Administration (HRSA) demonstrate that the total supply of orthopedic surgeons is set to decline from 31,980 in 2025 to 30,620 by 2037, creating a projected national shortfall of more than 5,000 orthopedic surgeons against surging patient demand [5].

We cannot ask our remaining aging surgeons to double their manual caseloads to compensate, as the physical and mental tolls are simply too high. Digitization and autonomous surgical robotics can bridge this exact 20-year experience gap. By digitizing and standardizing complex workflows through Physical AI, hospitals can elevate the baseline performance of less experienced surgeons to match the consistency of a seasoned master on day one.

3. The End of the “Razor and Blade” Model

Historically, surgical robotics operated on a “razor and blade” business model. In particular in the hard tissue field, medical device companies used early generation, single-arm robots as Trojan horses to lock hospitals into proprietary, exorbitantly expensive implant ecosystems. This approach restricts hospitals and frustrates surgeons.

The future belongs to the instrument-agnostic platforms and ecosystems. By utilizing robotic systems capable of handling a large variety of generic instruments and 3rd party implants, hospitals liberate themselves from vendor lock-in. This operational freedom immediately lowers supply chain costs and brings the focus back to clinical excellence rather than corporate compliance.

4. The Three Revenue Pillars of Autonomous Surgery and the New Data Economy

As established in our previous analysis on the surgical data economy, the financial gravity of healthcare is shifting away from implanted hardware and toward a far more potent asset: intraoperative data [6]. However, algorithms cannot optimize clinical or financial outcomes in a vacuum. They require a physical system to capture high-fidelity metrics directly at the point of care and to be able to execute upon it [6].

First-generation orthopedic and spine robots cannot support a data-driven business model because their clinical participation is severely restricted [6]. Multi-center clinical registry data from the PRoGRSS study reveals that while thoracolumbar spine procedures average 196 minutes, traditional single-arm robots are actively used for just 31 minutes, or 16 percent of the total operating time [6, 7]. Once pedicle screw trajectories are aligned, these legacy machines are removed from the surgical field, leaving critical phases such as decompression and rod placement completely unrecorded [6].

Unlocking the economics of Surgery 3.0 requires a next level, multi-application robotic platform that remains engaged throughout the entire operation across diverse hard tissue specialties [6]. By transforming previously unmonitored manual steps into quantified digital workflows, the platform bridges preoperative planning, physical execution, and postoperative recovery into a unified financial and clinical ledger [6].

This continuous intraoperative presence transforms the commercial architecture of medical technology, anchoring it on three primary revenue pillars that correspond directly to new hospital reimbursement and efficiency frameworks [6]:

4.1. Capital Hardware Sales and Federated Data Monetization

Under the first pillar, the initial capital outlay for the robotic platform no longer has to sit on the hospital balance sheet as a static, depreciating expense [6]. As outlined in the Surgical Data as a Service (DaaS) framework, a comprehensive humanoid robot functions as an active clinical node within a decentralized federated learning architecture [6, 8]. This allows healthcare institutions to contribute anonymized biomechanical and kinematic parameters to global Physical AI models without raw patient data ever leaving the hospital firewall [6, 8]. This mechanism aligns directly with the European Union’s European Health Data Space (EHDS) regulation, which establishes a formal legal structure for the secondary commercial and research use of health data generated by medical devices [11]. Consequently, hospital networks can leverage their procedural data volume to negotiate subsidized hardware acquisition structures with robotics manufacturers [6].

4.2. Service Agreements and Pay-Per-Insight Supply Chain Optimization

The second pillar expands traditional service and maintenance contracts into predictive operational subscriptions [6]. By aggregating anatomical and instrumentation metrics across thousands of cases, the platform’s analytics engine accurately forecasts the exact implants and tools required prior to incision, enabling a “pay-per-insight” inventory model [6]. In conventional orthopedic workflows, vendors and hospitals absorb massive financial overhead by storing redundant consignment implants on-site and repeatedly sterilizing unused instruments [6]. Peer-reviewed studies published through the National Institutes of Health (NIH) demonstrate that data-driven rationalization of orthopedic surgical trays reduces tray volume by 62.1 percent and cuts sterilization expenses by 63.5 percent [9]. Coupling an instrument-agnostic humanoid platform with open, software-defined operating room architectures (such as the multisided market validated in the OP 4.1 initiative) strips away hidden supply chain inflation while generating recurring analytics revenue for the platform provider [6, 12].

4.3. Procedure-Based Software Licenses and Mandatory Value-Based Care

The third pillar replaces proprietary implant markups with dynamic, procedure-based Software-as-a-Service (SaaS) licensing [6]. Hospitals license specific autonomous Physical AI modules per case, while the robot simultaneously generates an objective digital audit of surgical execution, tracking micromillimeter alignment and bone resection tolerances [6]. This verifiable quality ledger is critical as government payers enforce strict financial accountability. In the United States, the Centers for Medicare & Medicaid Services (CMS) has introduced the mandatory Transforming Episode Accountability Model (TEAM), running from 2026 through 2030, which places acute care hospitals under two-sided financial risk for 30-day episodes in spinal fusion and joint replacement [10]. By proving adherence to optimal biomechanical parameters, hospitals can utilize robotic execution logs to justify premium Current Procedural Terminology (CPT) tiers, capture maximum CMS quality-adjusted payouts, and insulate their operating margins from post-acute penalty clawbacks [6, 10].

5. The Financial Argument for Hospitals: Throughput, Revisions, and Capital Investment

The core financial argument for adopting Physical AI is not about replacing the surgeon. It is about transforming the surgeon into a cognitive orchestrator capable of parallel sequencing [17].

Operating room time is an incredibly expensive resource, with peer-reviewed orthopedic business analyses indicating a mean inflation-adjusted cost of $46.04 per minute [13]. In a traditional surgical workflow, the utilization of this expensive asset is bottlenecked by the physical availability of the primary attending surgeon, who must remain scrubbed in from skin-to-skin. However, a highly capable humanoid robotic system simplifies entire portions of the procedure, such as repetitive bone milling and pedicle tract preparation, and executes them autonomously under the supervision of qualified surgical staff rather than the scarce primary surgeon. By delegating these routine, mathematically defined phases to supervised robotic execution, hospitals unlock true multi-room parallel sequencing [17, 18]. In this model, the primary attending surgeon is only required in each individual operating room for the critical cognitive portions of the surgery, which constitute roughly 30 to 40 percent of the total door-to-door procedure duration [18, 19]. Moving seamlessly between two staggered operating theaters to perform only the high-complexity surgical steps allows a single master surgeon to nearly double their daily surgical throughput without compromising patient safety, as validated in large-scale orthopedic overlapping surgery cohorts and National Health Service (NHS) High-Intensity Theatre (HIT) parallel processing initiatives [18, 20, 21].

Furthermore, surgical precision driven by Physical AI prevents costly adverse events and the need for revision surgeries, which severely degrade hospital margins. Data from the UK National Health Service (NHS) “Getting It Right First Time” (GIRFT) orthopedic program demonstrates that post-operative complications and deep infections in joint arthroplasty cost up to £70,000 per patient, whereas eliminating preventable revisions saves the public healthcare system between £200 million and £300 million annually, freeing up capacity for 40,000 to 60,000 additional primary surgeries each year [14]. Even in standard non-septic cases, tertiary referral center audits show that complex class R3 revision episodes reach £17,857 per case, generating substantial financial losses against standard reimbursement tariffs. Beyond direct surgical costs, prolonged recovery and productivity loss contribute to a broader economic impact. By ensuring absolute accuracy the first time through autonomous robotic execution, hospitals fundamentally protect their bottom line while compensating for the systemic loss of experienced hands.

Of course, adding multiple autonomous robots to hospitals entails capital costs, and transitioning to a multi-room sequencing plan involves operational investments, requiring additional operating rooms, nurses, and allied surgical personnel and clinical support. Yet this highlights the most critical macroeconomic reality of the coming decades: driven by a rapidly aging global population, hospitals and national health systems will be forced to invest massively in infrastructure to keep pace with surging patient demand. While physical facilities and allied surgical personnel and clinical support can be trained and scaled within a five-year window, primary attending surgeons cannot. As demonstrated by workforce projections, no amount of government funding can compress the mandatory 20 years of education, residency, and clinical experience required to mint a master surgeon. This makes the experienced primary surgeon the ultimate irreplaceable bottleneck, and multi-room autonomous sequencing is the only viable economic and operational bridge to solve this permanent scarcity.

6. Summary

The transition to Surgery 3.0 is inevitable. The convergence of a retiring master-class surgical workforce and tightening hospital budgets leaves healthcare systems with no alternative [1, 2]. Autonomous surgical robotics powered by Physical AI is the only scalable, data-driven solution that simultaneously elevates patient care, bridges the critical two-decade experience gap, and secures hospital profitability [1, 2, 5].

This article was written by a Physical Human with the assistance of Artificial Intelligence.

Works Cited

1. National Institutes of Health (NIH) / PubMed Central. Demographic analysis of practicing surgeons and aging workforce trends. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10963432/.
2. Association of American Medical Colleges (AAMC). Research Shows Shortage of More Than 100,000 Doctors by 2030. Available at: https://www.aamc.org/news/research-shows-shortage-more-100000-doctors-2030.
3. American Academy of Orthopaedic Surgeons (AAOS). Redefining Retirement: Orthopaedic Workforce Demographic Projections. Available at: https://www.aaos.org/globalassets/quality-and-practice-resources/career-center/aaos-redefining-retirement.pdf.
4. Journal of Bone and Joint Surgery / NIH PubMed Central. Geospatial Mapping of Orthopaedic Surgeons Age 60 and Over. PMC7224628. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7224628/.
5. National Institutes of Health (NIH) / PubMed. Analysis of United States Federal Government Projections on the Supply and Demand of Orthopedic Surgeons to 2037. PMID: 41636430. Available at: https://pubmed.ncbi.nlm.nih.gov/41636430/.
6. Bar, Y. (2026). Data is the New Commodity, While the Surgical Robot is the True Enabler of the New Economy. LEM Surgical Thought Leadership Series, July 9, 2026.
7. PRoGRSS Study Group / NIH PubMed Central. Comprehensive Outcomes Following Navigated Robotics in Thoracolumbar Spine Surgery: The PRoGRSS Final Analysis. Global Spine Journal. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12861404/.
8. Chaudjary, S., Kakkar, R., Gupta, R., et al. (2022). Blockchain and federated learning-based security solutions for telesurgery system: a comprehensive review. Turkish Journal of Electrical Engineering and Computer Sciences, 30, 2446-2488.
9. National Institutes of Health (NIH) / PubMed Central. Rationalization of Orthopaedic Surgical Instrument Trays: A Cost-Effective Practice. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8708479/.
10. Centers for Medicare & Medicaid Services (CMS). Transforming Episode Accountability Model (TEAM) Official Overview and Mandatory Episode Guidelines. U.S. Department of Health and Human Services. Available at: https://www.cms.gov/priorities/innovation/team-frequently-asked-questions.
11. European Commission / Directorate-General for Health and Food Safety. European Health Data Space Regulation (EHDS): Framework for Primary and Secondary Use of Electronic Health Data. Official Journal of the European Union. Available at: https://health.ec.europa.eu/ehealth-digital-health-and-care/european-health-data-space-regulation-ehds_en.
12. Görtz, M., Byczkowski, M., Rath, M., et al. / NIH PubMed Central (2022). A Platform and Multisided Market for Translational, Software-Defined Medical Procedures in the Operating Room (OP 4.1): Proof-of-Concept Study. JMIR Medical Informatics. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8814925/.
13. Rajani, R., & Childs, B. The Cost of OR Time is $46.04 per Minute. Journal of Orthopaedic Business, 2(4), 10-13. Available at: https://jorthobusiness.org/index.php/jorthobusiness/article/view/23.
14. UK National Health Service (NHS) / NIH PubMed Central. Mixed methods evaluation of the Getting It Right First Time (GIRFT) national clinical improvement programme in orthopaedics. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9207914/.
15. ResearchGate / UK Tertiary Referral Centre Analysis. Revision Total Knee replacement finances: a detailed cost-analysis of operative practice at a regional tertiary referral centre. Available at: https://www.researchgate.net/publication/370856348_Revision_Total_Knee_replacement_finances_a_detailed_cost-analysis_of_operative_practice_at_a_regional_tertiary_referral_centre.
16. Brodie, A., & Vasdev, N. / NIH PubMed Central (2018). The future of robotic surgery. Annals of Medicine and Surgery, 36, 4-10. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6240886/.
17. National Institutes of Health (NIH) / PubMed Central. Increasing Operating Room Efficiency Through Parallel Processing. PMC1449970. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC1449970/.
18. Zachwieja, E., Yayac, M., Wills, B. W., et al. (2020). Overlapping Surgery Increases Operating Room Efficiency Without Adversely Affecting Outcomes in Total Hip and Knee Arthroplasty. The Journal of Arthroplasty, 35(6), 1529-1533. PMID: 32081499. Available at: https://pubmed.ncbi.nlm.nih.gov/32081499/.
19. Ravi, B., Pincus, D., Wasserstein, D., et al. / NIH PubMed Central (2017). Association of Overlapping Surgery With Increased Risk for Complications Following Hip Surgery: A Population-Based Cohort Study (Duration of Overlap and Critical Portions Analysis). JAMA Internal Medicine. PMC5833499. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC5833499/.
20. Hamilton, W. G., Ho, H., Parks, N. L., et al. (2018). The Lawrence D. Dorr Surgical Techniques & Technologies Award: “Running Two Rooms” Does Not Compromise Outcomes or Patient Safety in Joint Arthroplasty. The Journal of Arthroplasty, 33(7S), S8-S12. PMID: 29452974. Available at: https://pubmed.ncbi.nlm.nih.gov/29452974/.
21. Furrer, M. A., Ahmad, I., Noel, J., et al. / Guy’s and St Thomas’ NHS Foundation Trust & University of Bern (2023). High-intensity theatre (HIT) lists to tackle the elective surgery backlog. Nature Reviews Urology, 20, 453-454. PMC10195132. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC10195132/.